Clinical trial NCT03923933 - References

Renal Insufficiency, Chronic — Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial

Citation(s)

•   Agarwal R, Sinha AD, Pappas MK, Ammous F
  Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study. Am J Nephrol. 2014;39(2):171-82. doi: 10.1159/000358603. Epub 2014 Feb 11.
•   Akchurin OM, Kaskel F
  Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1-3):84-92. doi: 10.1159/000368940. Epub 2015 Jan 20. Review.
•   Andreucci M, Russo D, Fuiano G, Minutolo R, Andreucci VE
  Diuretics in renal failure. Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):32-8. Review.
•   Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL
  Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med. 2012 May;13(3):253-8. doi: 10.1097/PCC.0b013e31822882a3.
•   Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B, Saad S, Lunney M, Wiebe N, Ye F, Johnson DW
  Assessment of Global Kidney Health Care Status. JAMA. 2017 May 9;317(18):1864-1881. doi: 10.1001/jama.2017.4046.
•   Bennett WM, Porter GA
  Efficacy and safety of metolazone in renal failure and the nephrotic syndrome. J Clin Pharmacol. 1973 Aug-Sep;13(8):357-64.
•   Bowman BN, Nawarskas JJ, Anderson JR
  Treating Diuretic Resistance: An Overview. Cardiol Rev. 2016 Sep-Oct;24(5):256-60. doi: 10.1097/CRD.0000000000000116. Review.
•   Chang ST, Chen CL, Chen CC, Lin FC, Wu D
  Enhancement of quality of life with adjustment of dry weight by echocardiographic measurement of inferior vena cava diameter in patients undergoing chronic hemodialysis. Nephron Clin Pract. 2004;97(3):c90-7.
•   Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee
  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. Epub 2003 May 14. Erratum in: JAMA. 2003 Jul 9;290(2):197.
•   Cirillo M, Marcarelli F, Mele AA, Romano M, Lombardi C, Bilancio G
  Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function. Hypertension. 2014 Apr;63(4):692-7. doi: 10.1161/HYPERTENSIONAHA.113.02793. Epub 2014 Jan 6.
•   Collins AJ, Foley RN, Gilbertson DT, Chen SC
  United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015 Jun;5(1):2-7.
•   Craswell PW, Ezzat E, Kopstein J, Varghese Z, Moorhead JF
  Use of metolazone, a new diuretic, in patients with renal disease. Nephron. 1974;12(1):63-73.
•   Dargie HJ, Allison ME, Kennedy AC, Gray MJ
  Efficacy of metolazone in patients with renal edema. Clin Nephrol. 1974;2(4):157-60.
•   Dargie HJ, Allison ME, Kennedy AC, Gray MJ
  High dosage metolazone in chronic renal failure. Br Med J. 1972 Oct 28;4(5834):196-8.
•   Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O'Donoghue DJ, Morton RL, Obrador GT; Kidney Disease: Improving Global Outcomes
  Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int. 2015 Sep;88(3):447-59. doi: 10.1038/ki.2015.110. Epub 2015 Apr 29.
•   Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C
  Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med. 2015 Oct;5(4):254-66. doi: 10.1159/000435838. Epub 2015 Jul 15. Review.
•   Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y
  A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. J Clin Hypertens (Greenwich). 2012 Jan;14(1):32-7. doi: 10.1111/j.1751-7176.2011.00564.x. Epub 2011 Dec 9.
•   Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y
  A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant. 2005 Feb;20(2):349-53. Epub 2004 Dec 22.
•   Ekinci C, Karabork M, Siriopol D, Dincer N, Covic A, Kanbay M
  Effects of Volume Overload and Current Techniques for the Assessment of Fluid Status in Patients with Renal Disease. Blood Purif. 2018;46(1):34-47. doi: 10.1159/000487702. Epub 2018 Apr 12. Review.
•   Ellison DH, Felker GM
  Diuretic Treatment in Heart Failure. N Engl J Med. 2017 Nov 16;377(20):1964-1975. doi: 10.1056/NEJMra1703100. Review. Erratum in: N Engl J Med. 2018 Feb 1;378(5):492.
•   Fliser D, Schröter M, Neubeck M, Ritz E
  Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int. 1994 Aug;46(2):482-8.
•   Hassinger AB, Wald EL, Goodman DM
  Early postoperative fluid overload precedes acute kidney injury and is associated with higher morbidity in pediatric cardiac surgery patients. Pediatr Crit Care Med. 2014 Feb;15(2):131-8. doi: 10.1097/PCC.0000000000000043.
•   Hoorn EJ, Ellison DH
  Diuretic Resistance. Am J Kidney Dis. 2017 Jan;69(1):136-142. doi: 10.1053/j.ajkd.2016.08.027. Epub 2016 Nov 1. Review.
•   Hung SC, Lai YS, Kuo KL, Tarng DC
  Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc. 2015 May 5;4(5). pii: e001918. doi: 10.1161/JAHA.115.001918.
•   James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E
  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809.
•   Khalaf FK, Dube P, Mohamed A, Tian J, Malhotra D, Haller ST, Kennedy DJ
  Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na?/K?-ATPase. Int J Mol Sci. 2018 Aug 30;19(9). pii: E2576. doi: 10.3390/ijms19092576. Review.
•   Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH
  Chronic Kidney Disease, Fluid Overload and Diuretics: A Complicated Triangle. PLoS One. 2016 Jul 21;11(7):e0159335. doi: 10.1371/journal.pone.0159335. eCollection 2016.
•   Knauf H, Mutschler E
  Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol. 1995 Sep;26(3):394-400.
•   Knepper MA
  Systems biology of diuretic resistance. J Clin Invest. 2015 May;125(5):1793-5. doi: 10.1172/JCI81505. Epub 2015 Apr 20.
•   Levey AS, Coresh J
  Chronic kidney disease. Lancet. 2012 Jan 14;379(9811):165-80. doi: 10.1016/S0140-6736(11)60178-5. Epub 2011 Aug 15. Review.
•   Magee G, Zbrozek A
  Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals. Clinicoecon Outcomes Res. 2013 Jun 26;5:289-96. doi: 10.2147/CEOR.S45873. Print 2013.
•   Maruta Y, Hasegawa T, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A
  Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study. Clin Exp Nephrol. 2019 Feb;23(2):215-222. doi: 10.1007/s10157-018-1631-x. Epub 2018 Aug 24.
•   Morton RL, Turner RM, Howard K, Snelling P, Webster AC
  Patients who plan for conservative care rather than dialysis: a national observational study in Australia. Am J Kidney Dis. 2012 Mar;59(3):419-27. doi: 10.1053/j.ajkd.2011.08.024. Epub 2011 Oct 20.
•   Murtagh FE, Addington-Hall JM, Edmonds PM, Donohoe P, Carey I, Jenkins K, Higginson IJ
  Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007 Dec;10(6):1266-76.
•   National Kidney Foundation
  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.
•   Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V
  Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017 Jul 6;2(2):e000380. doi: 10.1136/bmjgh-2017-000380. eCollection 2017.
•   REUBI FC, COTTIER PT
  Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation. 1961 Feb;23:200-10.
•   Roberts MA
  Commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease. Nephrology (Carlton). 2014 Jan;19(1):53-5. doi: 10.1111/nep.12168.
•   Shahin MH, Johnson JA
  Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response. Curr Opin Pharmacol. 2016 Apr;27:31-7. doi: 10.1016/j.coph.2016.01.005. Epub 2016 Feb 10. Review.
•   Thomas R, Kanso A, Sedor JR
  Chronic kidney disease and its complications. Prim Care. 2008 Jun;35(2):329-44, vii. doi: 10.1016/j.pop.2008.01.008. Review.
•   Titze J
  Interstitial fluid homeostasis and pressure: news from the black box. Kidney Int. 2013 Nov;84(5):869-71. doi: 10.1038/ki.2013.287.
•   Vaara ST, Korhonen AM, Kaukonen KM, Nisula S, Inkinen O, Hoppu S, Laurila JJ, Mildh L, Reinikainen M, Lund V, Parviainen I, Pettilä V; FINNAKI Study Group
  Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012 Oct 17;16(5):R197. doi: 10.1186/cc11682.
•   van de Luijtgaarden MW, Noordzij M, van Biesen W, Couchoud C, Cancarini G, Bos WJ, Dekker FW, Gorriz JL, Iatrou C, Wanner C, Finne P, Stojceva-Taneva O, Cala S, Stel VS, Tomson C, Jager KJ
  Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. Nephrol Dial Transplant. 2013 Oct;28(10):2604-12. doi: 10.1093/ndt/gft287. Epub 2013 Sep 7.
•   Verberne WR, Dijkers J, Kelder JC, Geers ABM, Jellema WT, Vincent HH, van Delden JJM, Bos WJW
  Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study. BMC Nephrol. 2018 Aug 16;19(1):205. doi: 10.1186/s12882-018-1004-4.
•   Wilcox CS
  New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol. 2002 Mar;13(3):798-805. Review.
•   Wollam GL, Tarazi RC, Bravo EL, Dustan HP
  Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med. 1982 Jun;72(6):929-38.
•   Wong SP, Hebert PL, Laundry RJ, Hammond KW, Liu CF, Burrows NR, O'Hare AM
  Decisions about Renal Replacement Therapy in Patients with Advanced Kidney Disease in the US Department of Veterans Affairs, 2000-2011. Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1825-1833. doi: 10.2215/CJN.03760416. Epub 2016 Sep 22.
•   Yatime L, Laursen M, Morth JP, Esmann M, Nissen P, Fedosova NU
  Structural insights into the high affinity binding of cardiotonic steroids to the Na+,K+-ATPase. J Struct Biol. 2011 May;174(2):296-306. doi: 10.1016/j.jsb.2010.12.004. Epub 2010 Dec 21.
•   Yugar LBT, Moreno B, Moreno H, Vilela-Martin JF, Yugar-Toledo JC
  Do thiazide diuretics reduce central systolic blood pressure in hypertension? J Clin Hypertens (Greenwich). 2018 Jan;20(1):133-135. doi: 10.1111/jch.13134. Epub 2017 Nov 6.

Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial

Details for clinical trial NCT03923933